ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,569,533 | -12.3% | 728,275 | -15.9% | 0.00% | -25.0% |
| Q2 2023 | $10,911,285 | +62974.7% | 865,975 | -34.7% | 0.00% | -33.3% |
| Q1 2023 | $17,299 | -29.8% | 1,325,561 | -5.0% | 0.01% | -40.0% |
| Q4 2022 | $24,626 | -99.9% | 1,396,060 | +4.6% | 0.01% | +25.0% |
| Q3 2022 | $20,334,000 | -9.8% | 1,335,096 | -12.2% | 0.01% | -11.1% |
| Q2 2022 | $22,555,000 | -32.7% | 1,520,884 | +0.8% | 0.01% | -18.2% |
| Q1 2022 | $33,505,000 | +84.4% | 1,508,579 | +53.2% | 0.01% | +120.0% |
| Q4 2021 | $18,165,000 | +20.8% | 984,552 | -12.5% | 0.01% | 0.0% |
| Q3 2021 | $15,043,000 | -51.4% | 1,125,177 | -32.7% | 0.01% | -44.4% |
| Q2 2021 | $30,954,000 | +3.8% | 1,672,319 | -15.8% | 0.01% | 0.0% |
| Q1 2021 | $29,830,000 | +0.7% | 1,986,713 | -3.2% | 0.01% | -10.0% |
| Q4 2020 | $29,626,000 | +145.8% | 2,051,654 | +38.6% | 0.01% | +100.0% |
| Q3 2020 | $12,053,000 | +17.6% | 1,480,775 | -2.2% | 0.01% | +25.0% |
| Q2 2020 | $10,252,000 | +5.2% | 1,514,410 | +9.4% | 0.00% | -20.0% |
| Q1 2020 | $9,744,000 | +7.1% | 1,384,129 | +49.3% | 0.01% | +66.7% |
| Q4 2019 | $9,098,000 | +6.4% | 927,028 | +19.0% | 0.00% | 0.0% |
| Q3 2019 | $8,553,000 | -5.7% | 778,959 | -0.1% | 0.00% | -25.0% |
| Q2 2019 | $9,072,000 | +1136.0% | 780,048 | +1247.5% | 0.00% | 0.0% |
| Q1 2017 | $734,000 | +0.1% | 57,889 | -19.4% | 0.00% | 0.0% |
| Q4 2016 | $733,000 | -71.5% | 71,783 | -63.2% | 0.00% | -73.3% |
| Q3 2016 | $2,571,000 | -13.2% | 195,237 | -16.3% | 0.02% | -16.7% |
| Q2 2016 | $2,962,000 | +60.5% | 233,237 | +66.9% | 0.02% | +80.0% |
| Q1 2016 | $1,846,000 | +56.4% | 139,737 | +82.1% | 0.01% | +66.7% |
| Q4 2015 | $1,180,000 | +45.9% | 76,737 | +17.7% | 0.01% | +20.0% |
| Q3 2015 | $809,000 | -9.3% | 65,207 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $892,000 | +14.4% | 65,207 | 0.0% | 0.01% | +25.0% |
| Q1 2015 | $780,000 | -17.1% | 65,207 | -11.5% | 0.00% | -20.0% |
| Q4 2014 | $941,000 | -4.9% | 73,688 | 0.0% | 0.01% | -16.7% |
| Q3 2014 | $989,000 | -12.3% | 73,688 | +4.9% | 0.01% | -14.3% |
| Q2 2014 | $1,128,000 | -10.7% | 70,266 | +0.3% | 0.01% | -12.5% |
| Q1 2014 | $1,263,000 | +16.6% | 70,068 | 0.0% | 0.01% | +14.3% |
| Q4 2013 | $1,083,000 | -58.0% | 70,068 | -59.6% | 0.01% | -58.8% |
| Q3 2013 | $2,580,000 | +168.2% | 173,504 | +133.4% | 0.02% | +183.3% |
| Q2 2013 | $962,000 | – | 74,335 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |